Efficacy and safety of PD-1/PD-L1 inhibitors combined with CTLA-4 inhibitor versus chemotherapy for advanced lung cancer: A meta-analysis

BACKGROUND: This meta-analysis was performed to compare efficacy and tolerability between antiprogrammed cell death (PD-1)/programmed cell death-ligand-1 (PD-L1) + anticytotoxic T-lymphocyte-associated protein-4 (CTLA-4) treatment and chemotherapy in advanced lung cancer. METHODS: Cochrane Library,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Pei-Pei, Wang, Juan, Ding, Da-Zhi, Zhang, Li, Cheng, Chun, Chen, Da-Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416009/
https://www.ncbi.nlm.nih.gov/pubmed/34477154
http://dx.doi.org/10.1097/MD.0000000000027121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416009/
https://www.ncbi.nlm.nih.gov/pubmed/34477154
http://dx.doi.org/10.1097/MD.0000000000027121

Ejemplares similares